Search research articles
Contact Us
Filters
Showing results (171-180 of 220) with videos related to
Page
of 22
Sort By:
European Journal of Gynaecological Oncology
|
March 6, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study
Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, et al.
Gynecologic Oncology
|
April 12, 2025
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)
Thomas J Herzog, John B Liao, Karen Finkelstein, et al.
The British Journal of Dermatology
|
August 14, 2019
Genetic alterations in primary melanoma in Taiwan
Y-S Sheen, K-T Tan, K-P Tse, et al.
Journal of Gynecologic Oncology
|
May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses
Jung-Yun Lee, Ana Oaknin, Luis Manso, et al.
British Journal of Cancer
|
March 21, 2013
AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1
Z-T Tong, J-H Wei, J-X Zhang, et al.
Zhonghua Fu Chan Ke Za Zhi
|
July 20, 2023
[Comparison of the effects and safety of dydrogesterone and medroxyprogesterone acetate on endometrial hyperplasia without atypia: a randomized controlled non-inferior phase Ⅲ clinical study]
Y C Lou, S Zhou, J B Liao, et al.
Scientific Reports
|
December 3, 2017
Structural responses of metallic glasses under neutron irradiation
L Yang, H Y Li, P W Wang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologies
T Wei, B Liao, B L Ackermann, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Journal for Immunotherapy of Cancer
|
June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 220) with videos related to
Sort By:
Page
of 22
European Journal of Gynaecological Oncology
|
March 6, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study
Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, et al.
Gynecologic Oncology
|
April 12, 2025
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)
Thomas J Herzog, John B Liao, Karen Finkelstein, et al.
The British Journal of Dermatology
|
August 14, 2019
Genetic alterations in primary melanoma in Taiwan
Y-S Sheen, K-T Tan, K-P Tse, et al.
Journal of Gynecologic Oncology
|
May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses
Jung-Yun Lee, Ana Oaknin, Luis Manso, et al.
British Journal of Cancer
|
March 21, 2013
AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1
Z-T Tong, J-H Wei, J-X Zhang, et al.
Zhonghua Fu Chan Ke Za Zhi
|
July 20, 2023
[Comparison of the effects and safety of dydrogesterone and medroxyprogesterone acetate on endometrial hyperplasia without atypia: a randomized controlled non-inferior phase Ⅲ clinical study]
Y C Lou, S Zhou, J B Liao, et al.
Scientific Reports
|
December 3, 2017
Structural responses of metallic glasses under neutron irradiation
L Yang, H Y Li, P W Wang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologies
T Wei, B Liao, B L Ackermann, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Journal for Immunotherapy of Cancer
|
June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
Page
of 22